Literature DB >> 15522549

Estrogen receptor beta and breast cancer.

P J Balfe1, A H McCann, H M Welch, M J Kerin.   

Abstract

A second estrogen receptor, estrogen receptor-beta, was identified in 1996 and has led to an intensive re-evaluation of the role of estrogens in normal physiological and disease processes. While much has been learnt about this new receptor, there remain many outstanding questions, particularly regarding its prognostic significance and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522549     DOI: 10.1016/j.ejso.2004.06.019

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

Review 1.  Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Authors:  Viroj Boonyaratanakornkit; Nalo Hamilton; Diana C Márquez-Garbán; Prangwan Pateetin; Eileen M McGowan; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2017-11-14       Impact factor: 4.102

2.  Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.

Authors:  Xianglin Wu; Malayannan Subramaniam; Vivian Negron; Muzaffer Cicek; Carol Reynolds; Wilma L Lingle; Matthew P Goetz; James N Ingle; Thomas C Spelsberg; John R Hawse
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

3.  Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?

Authors:  Petros D Grivas; Vassiliki Tzelepi; Georgia Sotiropoulou-Bonikou; Zinovia Kefalopoulou; Athanasios G Papavassiliou; Haralabos Kalofonos
Journal:  Int J Colorectal Dis       Date:  2009-02-06       Impact factor: 2.571

4.  Evaluation of Methylation Status in the 5'UTR Promoter Region of the DBC2 Gene as a Biomarker in Sporadic Breast Cancer.

Authors:  Mehri Hajikhan Mirzaei; Mehrdad Noruzinia; Hamid Karbassian; Yousef Shafeghati; Mousa Keyhanee; Ali Bidmeshki-Pour
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

5.  Expression analyses of nuclear receptor genes in breast cancer cell lines exposed to soy phytoestrogens after BRCA2 knockdown by TaqMan Low-Density Array (TLDA).

Authors:  Samir Satih; Hélène Savinel; Nadège Rabiau; Luc Fontana; Yves-Jean Bignon; Dominique J Bernard-Gallon
Journal:  J Mol Signal       Date:  2009-05-14

6.  Evaluating the potential bioactivity of a novel compound ER1626.

Authors:  Lijun Wang; Yanyan Zeng; Tianling Wang; Hongyi Liu; Hong Xiao; Hua Xiang
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.